Gujranwala Medical College (Urdu: گوجرانوالہ طبی کالج) is situated at Alipur Chatha Road Gujranwala, in the Province of Punjab, Pakistan. The college is the constituent college of the University of Health Sciences. Divisional Headquarter/Teaching Hospital Gujranwala is the attached hospital for this Medical College..
Acute normovolemic hemodilution (ANH) is a blood conservation strategy used in cardiac surgery, but its efficacy in reducing allogeneic blood transfusion remains debated. This systematic review and meta-analysis updates the existing evidence by incorporating recent randomized controlled trials (RCTs) to provide a contemporary assessment of ANH’s impact on perioperative transfusion outcomes. We searched PubMed/MEDLINE, Scopus, and Cochrane Central up to August 2025 for RCTs comparing ANH to standard care in adult cardiac surgery. Primary outcomes were the number of allogeneic red blood cell units transfused, the rate of allogeneic blood transfusion, and estimated total blood loss. Data were pooled using random-effects models, and subgroup analyses were performed by type of surgery. Thirty-one RCTs involving 4426 patients (ANH = 2242, control = 2184) were included. ANH significantly reduced the rate of allogeneic blood transfusion (risk ratio 0.75, 95% confidence interval [CI] 0.66–0.87; P < 0.0001), the number of allogeneic red blood cell units transfused (standardized mean difference −0.42, 95% CI −0.64 to −0.20; P = 0.0001), and estimated total blood loss (standardized mean difference −0.42, 95% CI −0.63 to −0.21; P < 0.0001). Substantial heterogeneity was observed. Subgroup analysis demonstrated that benefits were most consistent in patients undergoing coronary artery bypass grafting. In patients undergoing cardiac surgery, particularly coronary artery bypass grafting, ANH reduces exposure to allogeneic blood transfusion and decreases perioperative blood loss. Despite significant heterogeneity across studies, these findings support the inclusion of ANH within multimodal blood management protocols. Further large, high-quality RCTs with standardized protocols are warranted to confirm its role in modern practice.
Background: Individuals with inflammatory bowel disease (IBD) are at substantially increased risk for Clostridioides difficile infection (CDI), which leads to significantly higher morbidity and mortality compared to the general population. However, comprehensive national-level analyses of long-term mortality trends in this population remain limited. This study examines mortality trends associated with IBD and CDI in the United States from 1999 to 2023. Methods: This descriptive study utilized the CDC WONDER Multiple Cause-of-Death database. Deaths involving IBD (ICD-10: K50, K51) and CDI (A04.7) were identified among adults aged 25 years and older. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated with 95% confidence intervals and stratified by sex, race/ethnicity, urbanization, and census region. Joinpoint regression was applied to estimate the annual percent change (APC) in mortality. Results: Between 1999 and 2023, 76,084 deaths were recorded. Medical facilities accounted for 46% of deaths, followed by decedents’ homes (28.3%) and nursing home/long-term care facilities (16.5%). Overall mortality declined gradually from 1999 to 2018 (APC: −0.23, p < 0.05), increased sharply through 2021 (APC: +12.75, p < 0.05), and was then followed by a non-significant change through 2023 (APC: −2.69; 95% CI: −8.24 to 3.19), consistent with a plateau. Men consistently exhibited higher AAMRs than women. Non-Hispanic White individuals had the highest AAMRs (1.844 in 2023), while Non-Hispanic Black individuals experienced a sustained increase from 2016 onward (APC: +7.11, p < 0.05). Hispanic mortality increased steadily throughout the study period (APC: +1.31, p < 0.05). Rural populations had higher overall AAMRs than urban populations. The Midwest recorded the highest regional AAMRs by 2023 (1.867). Conclusions: Mortality increased significantly between 2018 and 2021, coinciding with the COVID-19 pandemic, though our study design cannot prove causation. Disparities by race/ethnicity, urbanization, and region persisted. These findings underscore the need for ongoing antibiotic stewardship, equitable healthcare access, and targeted public health interventions for this vulnerable population.
Spindle cell carcinoma (SpCC) is a rare and aggressive variant of squamous cell carcinoma characterized by a distinctive spindle-cell morphology and variable epithelial differentiation. It most frequently develops in the mucosal surfaces of the upper aerodigestive tract, particularly the larynx, hypopharynx, and oral cavity. Although maxillofacial involvement can occur, recurrent SpCC involving the cheek and mandibular region represents an uncommon clinical presentation and may pose significant diagnostic and therapeutic challenges. We report a case of recurrent spindle cell carcinoma involving the cheek and mandibular region following previous treatment. The patient presented with clinical features suggestive of a recurrent malignant lesion, and radiological evaluation demonstrated tumour involvement of the affected maxillofacial region. Histopathological examination revealed a highly atypical spindle-cell proliferation with malignant cytological features, raising consideration of several differential diagnoses, including spindle cell sarcoma, malignant fibrous histiocytoma, and other mesenchymal neoplasms. Given the unusual morphology and anatomical location, immunohistochemical evaluation was performed using a broad panel of epithelial and mesenchymal markers. The immunoprofile demonstrated epithelial differentiation and supported the diagnosis of spindle cell carcinoma, allowing distinction from primary mesenchymal spindle-cell malignancies. The recurrent nature of the lesion further emphasized the aggressive biological behaviour and potential for local recurrence associated with SpCC. Management of these tumours requires careful correlation of clinical, radiological, histopathological, and immunohistochemical findings, particularly when conventional squamous differentiation is inconspicuous. This case highlights the diagnostic complexity of recurrent SpCC in an uncommon cheek and mandibular location and emphasizes the importance of maintaining a high index of suspicion when evaluating recurrent spindle-cell lesions of the maxillofacial region. Early recognition, accurate pathological diagnosis, appropriate assessment of local and regional disease, and multidisciplinary management are essential for optimizing treatment and follow-up. Awareness of this rare presentation may facilitate timely diagnosis and improve clinical decision-making in patients with recurrent maxillofacial spindle cell carcinoma.